The role of cardiopulmonary bypass and surfactant in pulmonary decompensation after surgery for congenital heart disease.
Paul
D A
DA
Department of Pediatrics, Section of Neonatology, Christiana Hospital, Newark, DE, USA.
Greenspan
J S
JS
Davis
D A
DA
Russo
P
P
Antunes
M J
MJ
D015415:Biomarkers; D006348:Cardiac Surgical Procedures / Q000009:adverse effects*; D002315:Cardiopulmonary Bypass; D005260:Female; D005500:Follow-Up Studies; D006330:Heart Defects, Congenital / Q000601:surgery*; D006801:Humans; D007223:Infant; D008168:Lung / Q000378:metabolism* / Q000503:physiopathology; D008171:Lung Diseases / Q000209:etiology / Q000378:metabolism* / Q000503:physiopathology; D008297:Male; D011183:Postoperative Complications; D011379:Prognosis; D011663:Pulmonary Surfactants / Q000378:metabolism*; D012129:Respiratory Function Tests
D015415:Biomarkers; D011663:Pulmonary Surfactants